SkinDexes gives researchers access to secure longitudinal, patient-reported outcome data from across the dermatology spectrum — ethically collected, rigorously structured and ready for analysis.
Research capabilities
Continuous patient-reported outcomes collected daily — not just at clinic visits. Capture the full disease burden between appointments across weeks, months and years.
Structured, time-stamped photo diaries from consenting patients. Consistent capture protocols make images suitable for computational analysis and model training.
Data collected using validated instruments — EASI, DLQI, POEM, PASI, etc — ensuring compatibility with clinical trial endpoints and regulatory submissions.
All data is collected under explicit informed consent. Granular consent management, full audit trails and GDPR compliance built into the platform from day one.
Aggregate data across multiple clinical sites and geographies. Build diverse, representative cohorts that reflect real-world patient populations.
Identify eligible patients for clinical trials based on real-world disease activity, treatment history and demographic criteria — reducing recruitment timelines significantly.
Research applications
Generate RWE for regulatory submissions, health technology assessments and post-market surveillance studies using continuous, high-frequency patient data.
Track how patients respond to biologics, topicals and systemic therapies in real-world conditions — beyond the controlled environment of a clinical trial.
Correlate patient-reported triggers — diet, stress, weather, sleep, etc — with symptom flares to identify novel biomarkers and disease drivers.
Use real-world disease activity data to identify and pre-screen eligible patients, cutting recruitment timelines and improving cohort quality.
patient data points collected monthly
validated outcome measures supported
dermatological conditions tracked
patient data completeness rate
Partnership models
Access anonymised datasets for investigator-led studies. SkinDexes supports grant applications, data sharing agreements and co-authorship on publications.
Collaborate on real-world evidence programmes, post-approval studies and trial recruitment. Structured data licensing with full regulatory documentation.
Support NICE, EMA and FDA submissions with robust real-world outcome data that complements randomised trial evidence.
Get in touch with Lydia directly to discuss data access, cohort design and partnership models tailored to your programme.